MCW Cancer Center Welcomes World-Renowned AML Cancer Genomics Researcher Dr. Timothy Ley

Dr. Timothy Ley, a pioneering investigator in acute myeloid leukemia (AML) and cancer genomics, will present “The AML Genome” at the MCW Cancer Center Seminar Series.  

The talk will be held in Kerrigan Auditorium on Wednesday, March 20 from 4:00 to 5:00 PM.

Dr. Ley holds the Lewis T. and Rosalind B. Apple Chair in Oncology, is Professor of Medicine and of Genetics at Washington University, and serves as an Associate Director of The Genome Institute (for Cancer Genomics). 

He was invited to MCW by William Drobyski, MD.  Dr. Drobyski leads the Cancer Center’s Hematologic Malignancy & Transplantation program and is hosting Dr. Ley’s visit and lecture. 

“Dr. Ley is internationally recognized for his pioneering work in defining the AML genome, and is the recent recipient of the prestigious E. Donnall Thomas Prize from the American Society of Hematology.  We are honored to have him as our guest.”

Dr. David Margolis, professor and researcher in Pediatric Hematology/Oncology at MCW, attended Dr. Ley’s presentation to the ASH, and considers his visit a transformational opportunity for cancer research at MCW.

“He probably had no less than 10,000 hematologists in his hands as he went through one of the finest lectures I have ever heard, anywhere.  The inspiration and insight our students and investigators gain from his perspective could be transformational to cancer genomics on this campus.”

Dr. Ley will present “The AML Genome” at the Cancer Center Seminar Series on Wednesday, March 21, 2013, in Kerrigan Auditorium, MCW Medical Education Building.  His talk is open to the public and MCW faculty, staff, and students. 

Learn more about Dr. Ley and his work here.